British American Tobacco appoints new director

Published 10/02/2025, 12:04
British American Tobacco appoints new director

LONDON - British American Tobacco (NYSE:BTI) PLC (BAT (LON:BATS)) has announced the appointment of Uta Kemmerich-Keil as an independent Non-Executive Director, effective from February 17, 2025. Kemmerich-Keil will also serve on the company’s Audit and Nominations Committees.

Kemmerich-Keil’s previous roles include CEO of Personal Healthcare International at Procter & Gamble (NYSE:PG) from 2018 to 2020, and various leadership positions at Merck (NSE:PROR) Group, including CEO of the Consumer Health Division. She is currently a member of the Supervisory Board and Chair of the Audit Committee at Beiersdorf (ETR:BEIG).

BAT’s Chair of the Board, Luc Jobin, expressed confidence in Kemmerich-Keil’s background in regulated industries and her experience in consumer products, digital technology, and strategic transformation, stating these skills will be valuable to BAT’s goal of creating a smokeless future.

Concurrently, BAT announced that Murray S. Kessler will resign from the Board on February 17, 2025, to take on the role of Chief Executive Officer at Wellington International LLC. Jobin thanked Kessler for his contributions and insights during his tenure.

In related news, Karen Guerra, a Non-Executive Director at BAT, will join the Remuneration Committee and leave the Audit Committee as of February 10, 2025. The reshuffling follows a review of the Board Committees’ membership, which will see Darrell Thomas continue as Chair of the Audit Committee and Kandy Anand as Chair of the Remuneration Committee.

The changes to the Board and its committees come as part of BAT’s ongoing corporate governance and strategic planning. These appointments and departures are based on a press release statement from British American Tobacco.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.